FGL1 and non-small cell lung carcinoma: Taken together, our results suggest that overexpression of FGL1 may contribute to NSCLC cell proliferation and apoptotic resistance, thus leading to EGFR-TKI acquired resistance; however, the exact mechanism remains unclear.